Objective: We describe survival in patients with oligo- and non-secretory multiple myeloma (MM). We refer to the whole group as non-measurable MM and compare it with secretory MM. Methods: Oligo-secretory MM was defined as M protein in serum <10 g/L and M protein in urine <200 measured as mg/day, mg/liter or mg/mmol creatinine. If patients had no M protein, they were defined as non-secretory. The groups were also subdivided by Free Light Chains (SFLC) level and ratio. Results: Out of 4325 patients with symptomatic MM in the Swedish Myeloma Registry during 2008-2016 eligible for the study, 389 patients (9%) had non-measurable MM. Out of these, 253 patients (6%) had oligo-secretory and 136 (3%) had non-secretory MM. Median survival for secret...
Advances in novel agents and treatment combinations have improved prognosis and increased disease-fr...
Multiple myeloma is a plasma cell malignancy characterized by clonal proliferation of plasma cells i...
Non-secretory myeloma is a myeloma subtype whose diagnosis, until a few years ago, was established b...
Background: The Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CAL...
Plasma cell disorders appear in various forms such as aggressive plasma cell leukemia (PCL), typical...
Background The Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM...
Copyright © 2008 American Society for Blood and Marrow Transplantation Published by Elsevier Inc.Non...
Abstract Background Nonsecretory multiple myeloma (NSMM) is a rare type of multiple myeloma (MM). Fe...
Introduction: The development of novel drugs with a different mechanism of action has led to conside...
<div><p>Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly dia...
Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborat...
AbstractNonsecretory myeloma (NSM) accounts for <5% of cases of multiple myeloma (MM). The outcome o...
Multiple myeloma (MM) is the second most common hematologic malignancy in the US. It is typically ch...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly diagnosed M...
Advances in novel agents and treatment combinations have improved prognosis and increased disease-fr...
Multiple myeloma is a plasma cell malignancy characterized by clonal proliferation of plasma cells i...
Non-secretory myeloma is a myeloma subtype whose diagnosis, until a few years ago, was established b...
Background: The Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CAL...
Plasma cell disorders appear in various forms such as aggressive plasma cell leukemia (PCL), typical...
Background The Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM...
Copyright © 2008 American Society for Blood and Marrow Transplantation Published by Elsevier Inc.Non...
Abstract Background Nonsecretory multiple myeloma (NSMM) is a rare type of multiple myeloma (MM). Fe...
Introduction: The development of novel drugs with a different mechanism of action has led to conside...
<div><p>Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly dia...
Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborat...
AbstractNonsecretory myeloma (NSM) accounts for <5% of cases of multiple myeloma (MM). The outcome o...
Multiple myeloma (MM) is the second most common hematologic malignancy in the US. It is typically ch...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly diagnosed M...
Advances in novel agents and treatment combinations have improved prognosis and increased disease-fr...
Multiple myeloma is a plasma cell malignancy characterized by clonal proliferation of plasma cells i...
Non-secretory myeloma is a myeloma subtype whose diagnosis, until a few years ago, was established b...